Page last updated: 2024-09-05

sk&f 107260 and sb 223245

sk&f 107260 has been researched along with sb 223245 in 2 studies

Compound Research Comparison

Studies (sk&f 107260)	Trials (sk&f 107260)	Recent Studies (post-2010) (sk&f 107260)	Studies (sb 223245)	Trials (sb 223245)	Recent Studies (post-2010) (sb 223245)
11	0	0	7	0	0

Protein Interaction Comparison

Protein	Taxonomy	sk&f 107260 (IC50)	sb 223245 (IC50)
Integrin beta-3	Homo sapiens (human)		0.145
Integrin alpha-V	Homo sapiens (human)		0.145

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali, FE; Callahan, JF; Calvo, RR; Huffman, WF; Hwang, SM; Keenan, RM; Kopple, KD; Kwon, C; Miller, WH; Peishoff, CE; Samanen, JM; Wong, AS; Yuan, CK	1
Gottschalk, KE; Kessler, H; Lavecchia, A; Marinelli, L; Novellino, E	1

Other Studies

2 other study(ies) available for sk&f 107260 and sb 223245

Article	Year
Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists. Journal of medicinal chemistry, 1997, Jul-18, Volume: 40, Issue:15 Topics: Binding Sites; Oligopeptides; Protein Conformation; Receptors, Vitronectin	1997
Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design. Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21 Topics: Algorithms; Benzodiazepines; Crystallization; Crystallography, X-Ray; Drug Design; Hydrogen Bonding; Integrin alphaVbeta3; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Mutagenesis, Site-Directed; Oligopeptides; Protein Conformation; Stereoisomerism; Structure-Activity Relationship	2003

Article

Year

Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists.

Journal of medicinal chemistry, 1997, Jul-18, Volume: 40, Issue:15

Topics: Binding Sites; Oligopeptides; Protein Conformation; Receptors, Vitronectin

1997

Docking studies on alphavbeta3 integrin ligands: pharmacophore refinement and implications for drug design.

Journal of medicinal chemistry, 2003, Oct-09, Volume: 46, Issue:21

Topics: Algorithms; Benzodiazepines; Crystallization; Crystallography, X-Ray; Drug Design; Hydrogen Bonding; Integrin alphaVbeta3; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Mutagenesis, Site-Directed; Oligopeptides; Protein Conformation; Stereoisomerism; Structure-Activity Relationship

2003